Oral administration of gintonin attenuates cholinergic impairments by scopolamine, amyloid-β protein, and mouse model of Alzheimer’s disease

Molecules and Cells

Volumn 38, Issue 9, 2015, Pages 796-805

  Kim, Hyeon Joong ^a   Shin, Eun Joo ^b   Lee, Byung Hwan ^a   Choi, Sun Hye ^a   Jung, Seok Won ^a   Cho, Ik Hyun ^c   Hwang, Sung Hee ^d   Kim, Joon Yong ^a   Han, Jung Soo ^a   Chung, Chihye ^a   Jang, Choon Gon ^e   Rhim, Hyewon ^f   Kim, Hyoung Chun ^b   Nah, Seung Yeol ^a  

^a Konkuk University   (South Korea)

^b Kangwon National University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Sangji University   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Korea Institute of Science and Technology   (South Korea)

Author keywords

Acetylcholine; Cholinergic systems; Ginseng; Gintonin; LPA receptors

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; DONEPEZIL; GINTONIN; HERBACEOUS AGENT; NOOTROPIC AGENT; SCOPOLAMINE; UNCLASSIFIED DRUG; ACETYLCHOLINE; AMYLOID BETA PROTEIN[1-40]; PEPTIDE FRAGMENT; PLANT EXTRACT; SCOPOLAMINE BROMIDE;

ACETYLCHOLINE RELEASE; ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LEARNING DISORDER; LONG TERM CARE; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; MOUSE MODEL; NEURAL STEM CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PASSIVE AVOIDANCE TEST; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; C57BL MOUSE; CALCIUM SIGNALING; CELL CULTURE; CHEMICALLY INDUCED; CHOLINERGIC NERVE CELL; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; HIPPOCAMPUS; INSTITUTE FOR CANCER RESEARCH MOUSE; MEMORY DISORDERS; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TRANSGENIC MOUSE;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC NEURONS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MEMORY DISORDERS; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; NEURAL STEM CELLS; PEPTIDE FRAGMENTS; PLANT EXTRACTS; SCOPOLAMINE HYDROBROMIDE;

EID: 84947252234     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2015.0116     Document Type: Article

References (48)

1. Alzheimer, A. (1907). Uber eine eigenartige Erkrankung der Hirnrinde. Allg. Zeitschrife Psychiatr. 64, 146-148.
2. Bales, K.R., Tzavara, E.T., Wu, S., Wade, M.R., Bymaster, F.P., Paul, S.M., and Nomikos, G.G. (2006). Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J. Clin. Invest. 116, 825-832.
3. Bartus, R.T., Dean, R.L., Beer, B., and Lippa, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
4. Braak, H., Braak, E., Grundke-Iqbal, I., and Iqbal, K. (1986). Occurrence of neuropil threads in the senile human brain and in Alzheimer’s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci. Lett. 65, 351-355.
5. Castilla-Ortega, E., Sánchez-López, J., Hoyo-Becerra, C., Matas-Rico, E., Zambrana-Infantes, E., Chun, J., De Fonseca, F.R., Pedraza, C., Estivill-Torrús, G., and Santin, L.J. (2010). Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor. Neurobiol. Learn. Mem. 94, 73-82.
6. Castilla-Ortega, E., Hoyo-Becerra, C., Pedraza, C., Chun, J., Rodríguez De Fonseca, F., Estivill-Torrús, G., and Santin, L.J. (2011). Aggravation of chronic stress effects on hippocampal neurogenesis and spatial memory in LPA1 receptor knockout mice. PLoS One 6, 25522.
7. Castilla-Ortega, E., Pedraza, C., Chun, J., de Fonseca, F.R., Estivill-Torrús, G., and Santín, L.J. (2012). Hippocampal c-Fos activation in normal and LPA-null mice after two object recognition tasks with different memory demands. Behav. Brain Res. 232, 400-405.
8. Chao, L.P., and Wolfgram, F. (1972). Spectrophotometric assay for choline acetyltransferase. Anal. Biochem. 46, 114-118.
9. Choi, S.H., Jung, S.W., Kim, H.S., Kim, H.J., Lee B.H., Kim, J.Y., Kim J.H., Hwang, S.H., Rhim, H., Kim, HC., et al. (2015a). A brief method for the preparation of gintonin-enriched fraction from ginseng. J. Ginseng Res. doi:10.1016/j.jgr.2015.05.002 (in press).
10. Choi, S.H., Hong, M.K., Kim, H.J., Ryoo, N., Rhim, H., Nah, S.Y., and Kang, L.W. (2015b). Crystal structure of ginseng major latex-like protein 151 and its proposed lysophosphatidic acid-binding mechanism. Acta Crystallogr. D Biol. Crystallogr. 71, 1039-1050.
11. Colom, L.V., Castaneda, M.T., Hernandez, S., Perry, G., Jaime, S., Touhami, A. (2011). Intrahippocampal amyloid-ß (1-40) injections injure medial septal neurons in rats. Curr. Alzheimer Res. 8, 832-840.
12. Cui, H.L., and Qiao, J.T. (2006). Promotive action of lyso-phosphatidic acid on proliferation of rat embryonic neural stem cells and their differentiation to cholinergic neurons in vitro. Sheng Li Xue Bao 58, 547-555.
13. Dash, P.K., Orsi, S.A., Moody, M., and Moore, A.N. (2004). A role for hippocampal Rho-ROCK pathway in long-term spatial memory. Biochem. Biophys. Res. Commun. 322, 893-898.
14. Davie, B.J., Christopoulos, A., and Scammells, P.J. (2013). Development of M1 mAChR allosteric and bitopic ligands: prospective therapeutics for the treatment of cognitive deficits. ACS Chem. Neurosci. 4, 1026-1048.
15. Dubin, A.E., Bahnson, T., Weiner, J.A., Fukushima, N., and Chun, J. (1999). Lysophosphatidic acid stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts. J. Neurosci. 19, 1371-1381.
16. Van Der Flier, W.M., Van Den Heuvel, D.M.J., Weverling-Rijnsburger, A.W.E., Spilt, A., Bollen, E.L.E.M., Westendorp, R.G.J., Middelkoop, H.A.M., and Van Buchem, M.A. (2002). Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 59, 874-879.
17. Hasebe, N., Fujita, Y., Ueno, M., Yoshimura, K., Fujino, Y., and Yamashita, T. (2013). Soluble ß-amyloid Precursor Protein Alpha binds to p75 neurotrophin receptor to promote neurite outgrowth. PLoS One 8, e82321.
18. Hecht, J.H., Weiner, J.A., Post, S.R., and Chun, J. (1996). Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135, 1071-1083.
19. Heo, J.H., Lee, S.T., Chu, K., Oh, M.J., Park, H.J., Shim, J.Y., and Kim, M. (2008). An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease. Eur. J. Neurol. 15, 865-868.
20. Hooijmans, C.R., Rutters, F., Dederen, P.J., Gambarota, G., Veltien, A., van Groen, T., Broersen, L.M., Lütjohann, D., Heerschap, A., Tanila, H., et al. (2007). Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol. Dis. 28, 16-29.
21. Hwang, S.H., Shin, T.J., Choi, S.H., Cho, H.J., Lee, B.H., Pyo, M.K., Lee, J.H., Kang, J., Kim, H.J., Park, C.W., et al. (2012a). Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity. Mol. Cells 33, 151-162.
22. Hwang, S.H., Shin, E.J., Shin, T.J., Lee, B.H., Choi, S.H., Kang, J., Kim, H.J., Kwon, S.H., Jang, C.G., Lee, J.H., et al. (2012b). Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates alzheimer’s disease-related neuropathies: Involvement of non-amyloidogenic processing. J. Alzheimer’s Dis. 31, 207-223.
23. Hwang, S.H., Lee, B.H., Choi, S.H., Kim, H.J., Jung, S.W., Kim, H.S., Shin, H.C., Park, H.J., Park, K.H., Lee, M.K., et al. (2015). Gintonin, a novel ginseng-derived lysophosphatidic acid receptor ligand, stimulates neurotransmitter release. Neurosci. Lett. 584, 356-361.
24. Jaffar, S., Counts, S.E., Ma, S.Y., Dadko, E., Gordon, M.N., Morgan, D., and Mufson, E.J. (2001) Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Exp. Neurol. 170, 227-243.
25. Jin, C.H., Shin, E.J., Park, J.B., Jang, C.G., Li, Z., Kim, M.S., Koo, K.H., Yoon, H.J., Park, S.-J., Choi, W.-C., et al. (2009). Fustin flavonoid attenuates beta-amyloid (1-42)-induced learning impairment. J. Neurosci. Res. 87, 3658-3670.
26. Jung, B.D., Shin, E.J., Nguyen, X.K.T., Jin, C.H., Bach, J.H., Park, S.J., Nah, S.Y., Wie, M.B., Bing, G., and Kim, H.C. (2010). Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration. Neurochem. Int. 56, 229-244.
27. Kennedy, D.O., and Scholey, A.B. (2003). Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol. Biochem. Behav. 75, 687-700.
28. Kim, J.H., Choi, S., Jung, J.E., Roh, E.J., and Kim, H.J. (2006). Capacitative Ca2+ entry is involved in regulating soluble amyloid precursor protein (sAPPalpha) release mediated by muscarinic acetylcholine receptor activation in neuroblastoma SH-SY5Y cells. J. Neurochem. 97, 245-254.
29. Kim, B.-W., Yang, S., Lee, C.H., and Son, H. (2011). A critical time window for the survival of neural progenitor cells by HDAC inhibitors in the hippocampus. Mol. Cells 31, 159-164.
30. Kim, E.J., Jung, I.H., Van Le, T.K., Jeong, J.J., Kim, N.J., and Kim, D.H. (2013). Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. J. Ethnopharmacol. 146, 294-299.
31. Lee, S.T., Chu, K., Sim, J.Y., Heo, J.H., and Kim, M. (2008). Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 22, 222-226.
32. Liu, J.X., Cong, W.H., Xu, L., and Wang, J.N. (2004). Effect of combination of extracts of ginseng and ginkgo biloba on acetylcholine in amyloid beta-protein-treated rats determined by an improved HPLC. Acta Pharmacol. Sin. 25, 1118-1123.
33. Maurice, T., Lockhart, B.P., and Privat, A. (1996). Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res. 706, 181-193.
34. Pákáski, M., and Kálmán, J. (2008). Interactions between the amyloid and cholinergic mechanisms in Alzheimer’s disease. Neurochem. Int. 53, 103-111.
35. Park, H., Kim, S., Rhee, J., Kim, H.J., Han, J.S., Nah, S.Y., and Chung, C. (2015). Synaptic enhancement induced by gintonin via lysophosphatidic acid receptor activation in central synapses. J. Neurophysiol. 113, 1493-1500.
36. Pedraza, C., Sánchez-López, J., Castilla-Ortega, E., Rosell-Valle, C., Zambrana-Infantes, E., García-Fernández, M., Rodriguez de Fonseca, F., Chun, J., Santín, L.J., and Estivill-Torrús, G. (2014). Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors. Brain Struct. Funct. 219, 1659-1672.
37. Perez, S.E., Dar, S., Ikonomovic, M.D., DeKosky, S.T., and Mufson, E.J. (2007). Cholinergic Forebrain Degeneration in the APPswe/PS1 AE9 Transgenic Mouse. Neurobiol. Dis. 28, 3-15.
38. Pyo, M.K., Choi, S.-H., Hwang, S.H., Shin, T.J., Lee, B.H., Lee, S.M., Lim, Y.H., Kim, D.H., and Nah, S.Y. (2011). Novel Glycolipoproteins from Ginseng. J. Ginseng Res. 35, 92-103.
39. Shin, T.J., Kim, H.J., Kwon, B.J., Choi, S.H., Kim, H.B., Hwang, S.H., Lee, B.H., Lee, S.M., Zukin, R.S., Park, J.H., et al. (2012). Gintonin, a ginseng-derived novel ingredient, evokes long-term potentiation through N-methyl-D-aspartic acid receptor activation: involvement of LPA receptors. Mol. Cells 34, 563-572.
40. Shiono, S., Kawamoto, K., Yoshida, N., Kondo, T., and Inagami, T. (1993). Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors. Biochem. Biophys. Res. Commun. 193, 667-673.
41. Su, C.F., Cheng, J.T., and Liu, I.M. (2007). Increase of acetylcholine release by Panax ginseng root enhances insulin secretion in Wistar rats. Neurosci. Lett. 412, 101-104.
42. Sun, Y., Nam, J.S., Han, D.H., Kim, N.H., Choi, H.K., Lee, J.K., Rhee, H.J., and Huh, S.O. (2010). Lysophosphatidic acid induces upregulation of Mcl-1 and protects apoptosis in a PTX-dependent manner in H19-7 cells. Cell. Signal. 22, 484-494.
43. Tabuchi, S., Kume, K., Aihara, M., and Shimizu, T. (2000). Expression of lysophosphatidic acid receptor in rat astrocytes: mitogen-ic effect and expression of neurotrophic genes. Neurochem Res. 25, 573-582.
44. Trimbuch, T., Beed, P., Vogt, J., Schuchmann, S., Maier, N., Kintscher, M., Breustedt, J., Schuelke, M., Streu, N., Kieselmann, O., et al. (2009). Synaptic PRG-1 modulates excitatory transmis­sion via lipid phosphate-mediated signaling. Cell 138, 1222-1235.
45. Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., et al. (1999). Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
46. Wang, Q., Shin, E.J., Nguyen, X.K., Li, Q., Bach, J.H., Bing, G., Kim, W.K., and Kim, H.C., Hong, J.S. (2012). Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice. J. Neuroinflammation. 9, 124.
47. Wong, T.P., Debeir, T., Duff, K., and Cuello, A.C. (1999). Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci. 19, 2706-2716.
48. Yankner, B.A. (1996). Mechanisms of neuronal degeneration in Alzheimer’s disease. Neuron 16, 921-932.